Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f32e1d1c6f40a4b16f8e61568c8a6c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41fd2a6dccbf01389fde3a9308f62941 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7baebd416f8b139a77eb33639565e8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1394 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-052 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
filingDate |
2010-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8991d89f4c3113eeef2abe188a9948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b37a4555230bec42f37bf4c741ba171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74312768e7ba2b5aaa888b7d02c942b1 |
publicationDate |
2013-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013005035-A1 |
titleOfInvention |
Methods for generating t lymphocytes from hematopoietic stem cells |
abstract |
This disclosure describes methods for differentiating T cells and NK cells in vitro from hematopoietic stem cells or precursor cells. The technology is directed to methods for the production of selected populations of lymphocytes, such as T cells and NK cells. The availability of such cell populations allows for the complete reconstitution of a depleted, defective or missing lymphocyte population in a patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014248248-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533009-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266805-B2 |
priorityDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |